首页> 外国专利> - Betaglucan-peptide complexes preparation method thereof and pharmaceutical composition for use in preventing or treating inflammatory diseases containing the same as an active ingredient

- Betaglucan-peptide complexes preparation method thereof and pharmaceutical composition for use in preventing or treating inflammatory diseases containing the same as an active ingredient

机译:-β-葡聚糖-肽复合物的制备方法以及用于预防或治疗包含其作为有效成分的炎性疾病的药物组合物

摘要

The present invention relates to a betaglucan-peptide complex, a preparation method of the same, and a pharmaceutical composition for preventing or treating inflammatory diseases comprising the same as an active ingredient. Specifically, shizophyllan (SPG) which is beta-1,3-glucan, is covalently bound to SH3 peptide originated from c-Src to form SPG-c-Src-SH3 peptide complex, and the pharmaceutical composition comprises the complex as an active ingredient for preventing or treating inflammatory diseases such as sepsis and colitis. The betaglucan-peptide complex according to the present invention significantly reduces the production of active oxygen (ROS) and inflammatory cytokines by targeting p47phox, and thus can be beneficially used as a pharmaceutical composition for preventing or treating ROS-related life-threatening inflammatory diseases such as sepsis and colitis. Further, the betaglucan-peptide complex according to the present invention can be beneficially used in the development of novel peptide-based drugs targeting p47phox.
机译:贝塔葡聚糖-肽复合物,其制备方法以及用于预防或治疗包含其作为活性成分的炎性疾病的药物组合物。具体地,将β-1,3-葡聚糖的志贺兰素(SPG)与源自c-Src的SH3肽共价结合以形成SPG-c-Src-SH3肽复合物,并且该药物组合物包含该复合物作为活性成分。用于预防或治疗败血症和结肠炎等炎症性疾病。通过靶向p47phox,根据本发明的贝塔卢聚糖-肽复合物显着降低了活性氧(ROS)和炎性细胞因子的产生,因此可以有利地用作预防或治疗ROS相关的威胁生命的炎性疾病的药物组合物。如败血症和结肠炎。此外,根据本发明的贝他葡聚糖-肽复合物可有益地用于开发靶向p47phox的基于肽的新型药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号